Saltar al contenido
Merck
Todas las fotos(2)

Key Documents

MABT528

Sigma-Aldrich

Anti-Connexin 43 Antibody, CT Antibody, clone 1C5.1

clone 1C5.1, from mouse

Sinónimos:

Gap junction alpha-1 protein, Connexin-43, Cx43, Gap junction 43 kDa heart protein

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización


About This Item

UNSPSC Code:
12352203
eCl@ss:
32160702

biological source

mouse

Quality Level

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

1C5.1, monoclonal

species reactivity

rat, human

technique(s)

immunohistochemistry: suitable (paraffin)
western blot: suitable

isotype

IgG1κ

NCBI accession no.

UniProt accession no.

shipped in

ambient

target post-translational modification

unmodified

Gene Information

human ... GJA1(2697)

General description

Gap junction alpha-1 protein (UniProt P17302; also known as Connexin-43, Cx43, Gap junction 43 kDa heart protein) is encoded by the GJA1 (also known as AVSD3, CMDR, GJAL, HSS, ODDD) gene (Gene ID 2697) in human. A gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexins, through which materials of low molecular weight diffuse from one cell to a neighboring cell. Connexin-43 is a polytopic integral membrane protein oligomerizes into a hexamer or connexon. It is he most ubiquitously expressed connexin and contains a long C-terminal tail, an N-terminal domain, and multiple transmembrane domains. The C-terminal tail domain of human connexin-43 contains 50 amino acids and includes post-translational modification sites, as well as binding sites for transcription factors, cytoskeleton elements, and other proteins. The C-terminal tail regulates pH gating and channel assembly, whereas the N-terminal domain is involved in channel gating and oligomerization and controls the switch between channel open and closed states. Mutations in connexin-43 result in multiple disorders, such as oculodentodigital dysplasia that is characterized by microcornea, microphthalmia, and syndactyly of the fourth and fifth fingers. Connexin-43 is shown to negatively regulate growth of colon cancer cells, in part by enhancing apoptosis. Loss of connexin-43 expression in colorectal cancers is correlated with significantly shorter relapse-free and overall survival.

Ref.:
Sirnes, S et al. (2012). Int. J. Cancer 131, 570-581.
Naus, CC et al. (2010). Nat. Rev. Cancer. 10, 435-441.

Specificity

Clone 1C5.1 targets an epitope within the second half of the C-terminal cytoplasmic tail.

Immunogen

GST-tagged recombinant human connexin 43 C-terminal cytoplasmic tail fragment.

Application

Anti-Connexin 43, CT, clone 1C5.1, Cat. No. MABT528 is a mouse monoclonal antibody validated for use in Immunohistochemistry (Paraffin) and Western Blotting for the detection of connexin 43.
Immunohistochemistry Analysis: A 1:250-1,000 dilution from a representative lot detected cconnexin 43 in human cerebellum, heart muscle, and kidney tissue sections.

Quality

Evaluated by Western Blotting in HUVEC lysate.

Western Blotting Analysis: 10 ng/mL of this antibody detected connexin 43 in 10 µg of HUVEC lysate.

Target description

~43 kDa observed. 42.88/42.90 kDa (human/rat) calculated (Met1 removed). Uncharacterized bands may be observed in some lysate(s).

Linkage

Replaces: MAB3068

Physical form

Format: Purified

Other Notes

Concentration: Please refer to lot specific datasheet.

¿No encuentra el producto adecuado?  

Pruebe nuestro Herramienta de selección de productos.

Optional

Storage Class

12 - Non Combustible Liquids

wgk_germany

WGK 1


Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Aleksandra V Durkina et al.
Journal of pineal research, 73(1), e12798-e12798 (2022-04-07)
Melatonin treatment was reported to reduce the risk of cardiac arrhythmias, and crucial for this antiarrhythmic action was the effect of melatonin on activation spread. The aim of the present study was evaluation of the mechanisms of this activation enhancement. Experiments

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico